Celldex (CLDX) Tops Q4 EPS by 4c

March 14, 2017 4:03 PM

Celldex (NASDAQ: CLDX) reported Q4 EPS of ($0.30), $0.04 better than the analyst estimate of ($0.34). Revenue for the quarter came in at $1.97 million versus the consensus estimate of $1.08 million.

For earnings history and earnings-related data on Celldex (CLDX) click here.


Earnings Guidance